158 related articles for article (PubMed ID: 7563973)
1. Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats.
Onodera S; Shibata M; Tanaka M; Inaba N; Yamaura T; Ohnishi H
Jpn J Pharmacol; 1995 Jun; 68(2):161-73. PubMed ID: 7563973
[TBL] [Abstract][Full Text] [Related]
2. [Effect of FRG-8813, a new histamine H2-receptor antagonist, on gastric mucus production in rats].
Kagoshima M; Kodaira H; Tanaka M; Shimada H
Nihon Yakurigaku Zasshi; 1995 Dec; 106(6):385-92. PubMed ID: 8582686
[TBL] [Abstract][Full Text] [Related]
3. Effect of lafutidine, a novel histamine H2-receptor antagonist, on monochloramine-induced gastric lesions in rats: role of capsaicin-sensitive sensory neurons.
Umeda M; Fujita A; Nishiwaki H; Takeuchi K
J Gastroenterol Hepatol; 1999 Sep; 14(9):859-65. PubMed ID: 10535466
[TBL] [Abstract][Full Text] [Related]
4. Effects of the new histamine H2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage.
Ichikawa T; Ishihara K; Komuro Y; Kojima Y; Saigenji K; Hotta K
Life Sci; 1994; 54(10):PL159-64. PubMed ID: 7509019
[TBL] [Abstract][Full Text] [Related]
5. A novel histamine 2(H2) receptor antagonist with gastroprotective activity. II. Synthesis and pharmacological evaluation of 2-furfuryl-thio and 2-furfurylsulfinyl acetamide derivatives with heteroaromatic rings.
Hirakawa N; Matsumoto H; Hosoda A; Sekine A; Yamaura T; Sekine Y
Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):616-22. PubMed ID: 9579037
[TBL] [Abstract][Full Text] [Related]
6. Gastroprotective mechanism of lafutidine, a novel anti-ulcer drug with histamine H2-receptor antagonistic activity.
Onodera S; Shibata M; Tanaka M; Inaba N; Arai Y; Aoyama M; Lee B; Yamaura T
Arzneimittelforschung; 1999 Jun; 49(6):519-26. PubMed ID: 10417869
[TBL] [Abstract][Full Text] [Related]
7. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
8. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
Tanaka M; Banba M; Joko A; Moriyama Y
Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):377-86. PubMed ID: 11436515
[TBL] [Abstract][Full Text] [Related]
10. Effect of lafutidine, a histamine H2-receptor antagonist, on gastric mucosal blood flow and duodenal HCO3- secretion in rats: relation to capsaicin-sensitive afferent neurons.
Mimaki H; Kagawa S; Aoi M; Kato S; Satoshi T; Kohama K; Takeuchi K
Dig Dis Sci; 2002 Dec; 47(12):2696-703. PubMed ID: 12498288
[TBL] [Abstract][Full Text] [Related]
11. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of mucin biosynthesis in rat gastric mucosa by FRG-8813 and its structural analogs.
Ichikawa T; Ishihara K; Shibata M; Yamaura T; Saigenji K; Hotta K
Eur J Pharmacol; 1996 Feb; 297(1-2):87-92. PubMed ID: 8851171
[TBL] [Abstract][Full Text] [Related]
13. Lafutidine increases hepatic blood flow via potentiating the action of central thyrotropin-releasing hormone in rats.
Yoneda M; Kurosawa M; Watanobe H; Terano A
J Gastroenterol Hepatol; 2003 Feb; 18(2):177-84. PubMed ID: 12542603
[TBL] [Abstract][Full Text] [Related]
14. Effect of FRG-8813, a new-type histamine H(2)-receptor antagonist, on the recurrence of gastric ulcer after healing by drug treatment in rats.
Ajioka H; Miyake H; Matsuura N
Pharmacology; 2000 Aug; 61(2):83-90. PubMed ID: 10940781
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats.
Harada N; Okajima K
Dig Dis Sci; 2007 Feb; 52(2):469-77. PubMed ID: 17211693
[TBL] [Abstract][Full Text] [Related]
16. [Effects of FRG-8813, a new-type histamine H2-receptor antagonist, on the healing of gastric and duodenal ulcer in rats and spontaneously ulcerative mice].
Yamaura T; Shibata M; Chida Y; Inaba N; Onodera S; Ohnishi H
Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):411-20. PubMed ID: 1356898
[TBL] [Abstract][Full Text] [Related]
17. Gastro-protective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins.
Fukushima K; Aoi Y; Kato S; Takeuchi K
World J Gastroenterol; 2006 May; 12(19):3031-7. PubMed ID: 16718783
[TBL] [Abstract][Full Text] [Related]
18. Mixed antisecretory and gastroprotective activities of a new H2-antagonist containing a nitric oxide-donor furoxan moiety.
Sorba G; Gasco A; Coruzzi G; Adami M; Pozzoli C; Morini G; Bertaccini G
Arzneimittelforschung; 1997 Jul; 47(7):849-54. PubMed ID: 9272244
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons.
Kato S; Tanaka A; Kunikata T; Umeda M; Takeuchi K
Digestion; 2000; 61(1):39-46. PubMed ID: 10671773
[TBL] [Abstract][Full Text] [Related]
20. Sensitizing effects of lafutidine on CGRP-containing afferent nerves in the rat stomach.
Nishihara K; Nozawa Y; Nakano M; Ajioka H; Matsuura N
Br J Pharmacol; 2002 Mar; 135(6):1487-94. PubMed ID: 11906962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
